Black Rock Inc. Bluebird Bio, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 15,442,212 shares of BLUE stock, worth $5.56 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,442,212
Previous 15,178,562
1.74%
Holding current value
$5.56 Million
Previous $19.4 Million
22.11%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding BLUE
# of Institutions
151Shares Held
64.4MCall Options Held
264KPut Options Held
428K-
Vanguard Group Inc Valley Forge, PA10.5MShares$3.77 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.68MShares$1.69 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$1.68 Million0.02% of portfolio
-
State Street Corp Boston, MA3.84MShares$1.38 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.63MShares$587,2110.05% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $27.8M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...